Table 2.
Outcomes
| MICT (n = 14) | HIIT (n = 42) | ANCOVA | |||
|---|---|---|---|---|---|
| Baseline | Change | Baseline | Change | P-value | |
| Rate-Your-Plate | 56 ± 7 | 5 ± 5 | 56 ± 7 | 5 ± 5 | P = .46 |
| Average statin | 2.4 ± 0.7 | 0.1 ± 0.3 | 2.8 ± 0.5 | − 0.1 ± 0.5 | P = .30 |
| MetS variables | |||||
| MetS z-score | 5.7 ± 3.6 | − 0.8 ± 3.8 | 4.6 ± 3.4 | − 3.6 ± 2.9 | P < .001 |
| ATP III MetS score | 3.9 ± 0.7 | − 0.6 ± 1.0 | 3.6 ± 0.6 | − 1.2 ± 1.0 | P = .005 |
| Waist circumference, cm | 110 ± 11 | 1 ± 5 | 110 ± 10 | − 3 ± 5 | P = .01 |
| FBG, mg/dl | 130.4 ± 38.7 | − 3.9 ± 25.8 | 129.3 ± 37.3 | − 25.8 ± 34.8 | P < .001 |
| TG, mg/dl | 222.5 ± 80.1 | − 10.4 ± 105.3 | 185.5 ± 101.5 | − 67.8 ± 86.7 | P < .001 |
| HDL-c, mg/dl | 38.9 ± 10.8 | 6.4 ± 8.3 | 40.3 ± 9.8 | 3.8 ± 9.0 | P = .42 |
| SBP, mmHg | 122 ± 18 | 0 ± 25 | 122 ± 15 | − 6 ± 18 | P = .16 |
| DBP, mmHg | 71 ± 12 | 0 ± 13 | 68 ± 11 | − 7 ± 11 | P = .001 |
| Body composition | |||||
| Body weight, kg | 91.2 ± 14.4 | 0.6 ± 4.8 | 91.5 ± 16.3 | − 0.5 ± 4.9 | P = .45 |
| BMI, kg/m2 | 31.5 ± 4.2 | 0 ± 1.5 | 31.3 ± 4.7 | − 0.1 ± 1.7 | P = .83 |
| Fat mass, kg | 35.4 ± 6.6 | 0 ± 2.2 | 35.7 ± 8.5 | − 2.1 ± 2.1 | P = .002 |
| Body fat, % | 40.2 ± 4.9 | − 0.2 ± 1.4 | 39.9 ± 5.9 | − 1.8 ± 1.7 | P = .002 |
| Lean mass, kg | 53.5 ± 9.3 | − 0.9 ± 3.2 | 53.5 ± 9.8 | 0.9 ± 1.9 | P = .01 |
| Abdominal fat, % | 47.5 ± 5.2 | 0.1 ± 2.4 | 49.6 ± 5.7 | − 2.2 ± 2.6 | P = .004 |
| Peak VO2, ml/kg/min | 23.7 ± 7.1 | 1.4 ± 0.9 | 23.0 ± 6.3 | 5.0 ± 2.5 | P = .03 |
| PHQ-9 | 4.0 ± 2.1 | − 1.2 ± 3.6 | 4.0 ± 3.2 | − 1.6 ± 3.5 | P = .45 |
BMI body mass index, CR cardiac rehabilitation, DBP diastolic blood pressure, FBG fasting blood glucose, HDL-c high-density lipoprotein cholesterol, HIIT high-intensity interval training, MetS metabolic syndrome, MICT moderate-intensity continuous training, Peak VO2 peak oxygen consumed, PHQ-9 patient health questionnaire 9, SBP systolic blood pressure, TG triglycerides